IDiyas

For the Inventor, By the Inventor

Epalinges, Switzerland

Anergis S.a.


USPTO Granted Patents = 7



Forward Citations = 33

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Francois Spertini (7 out of 9 patents)

silverMedal Blaise Corthesy (5 out of 12 patents)

bronzeMedal Christophe Dominique Reymond (2 out of 7 patents)

4.  Alexander Kettner (0 patent)


7 patents:

1. 9808503 - Allergen peptide fragments and use thereof for treatment of birch pollen allergies (2017-11-07),
2. 9193773 - Allergen peptide fragments and use thereof for treatment of dust mite allergies (2015-11-24),
3. 9005627 - Contiguous overlapping peptides for treatment of ragweed pollen allergy (2015-04-14),
4. 8703144 - Allergen peptide fragments and use thereof for treatment of dust mite allergies (2014-04-22),
5. 8343503 - Contiguous overlapping peptides for treatment of birch pollen allergy (2013-01-01),
6. 8075897 - Allergen peptide fragments and use thereof (2011-12-13),
7. 7923209 - Allergen peptide fragments and use thereof (2011-04-12),
Anergis S.a. is a Swiss-based biopharmaceutical company focused on developing innovative allergy vaccines. Their products are designed to provide a long-lasting and efficient solution for patients suffering from allergies. Anergis uses cutting-edge technology to tailor vaccines to individual patients, making them more effective and reducing side effects. With a strong team of experts and a commitment to improving the lives of allergy sufferers, Anergis is a leader in the field of allergy immunotherapy.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#4 in Epalinges

#1,305 in Switzerland

...
Epalinges, Switzerland

Anergis S.a.

Forward Citations = 33

6 inventors:

goldMedal Francois Spertini (7 out of 9 patents)

silverMedal Blaise Corthesy (5 out of 12 patents)

bronzeMedal Christophe Dominique Reymond (2 out of 7 patents)

4.  Alexander Kettner (0 patent)

Please report any incorrect information to support@idiyas.com
Loading…